News | Radiology Imaging | July 29, 2020

Comprehensive Database of Medical Imaging Equipment

IMV Medical Information releases the most comprehensive database of installed medical imaging equipment in the U.S.

It covers every major modality, including breast imaging/mammography, fixed and portable C-arms (cath, IR/angio, hybrid, OR), CT, MRI, nuclear medicine, radiographic fluoroscopy, ultrasound and X-ray

July 29, 2020 — IMV Medical Information, part of Science and Medicine Group, announced the release of the latest edition of the IMV Medical imaging MasterFile containing information on more than 85,000 pieces of equipment installed at more than 12,000 imaging facilities in the U.S.

The product is designed to help imaging vendors find customers, verify the data their sales team are providing, and locate weak points in the competition. The IMV Medical imaging MasterFile is the most comprehensive database of the installed base of medical imaging equipment in the U.S. The ongoing survey of imaging facilities across the country continuously updates data on more than 84,000 imaging instruments, including manufacturer, model, number installed, year installed and department location. It covers every major modality, including breast imaging/mammography, fixed and portable C-arms (cath, IR/angio, hybrid, OR), CT, MRI, nuclear medicine, radiographic fluoroscopy, ultrasound and X-ray.

Key demographics such as address, population served, budget, and key points of contact are also included. The information provided by radiologists and facility managers at U.S. imaging sites is continuously gathered by phone and an online reporting system. Newly added this year is the ability to search based on planned purchases in 2020 providing hundreds of actionable leads.

“This enhanced database provides our clients with opportunities to target imaging departments with old or outdated equipment and helps pinpoint where the competition is strong or vulnerable,” said Jonathan West, VP, Clinical Business Development. “Our database can be linked to sources of IDN data so that you can understand the resources of an entire IDN to supplement and verify information collected by your sales team."

For more information: https://imvinfo.com/product/masterfile-diagnostic-imaging/

Related Content

New Module Creates a Warped MRI Scan that Matches Real-Time Ultrasound Results (Graphic: Business Wire)

New Module Creates a Warped MRI Scan that Matches Real-Time Ultrasound Results (Graphic: Business Wire)

News | Artificial Intelligence | May 07, 2021
News | Radiation Therapy | May 06, 2021
May 6, 2021 — Individuals living with severe...
3D aMRI not only provides a stunning look inside the "beating brain", but it can also measure this physiological motion in all directions. Here, the amplitude of brain motion is overlayed for each brain slice and orientation in 3D. Image credit: 3D aMRI method outlined in Abderezaei et al. Brain Multiphysics (2021); Terem et al. Magnetic Resonance in Medicine (2021).

3D aMRI not only provides a stunning look inside the "beating brain", but it can also measure this physiological motion in all directions. Here, the amplitude of brain motion is overlayed for each brain slice and orientation in 3D. Image credit: 3D aMRI method outlined in Abderezaei et al. Brain Multiphysics (2021); Terem et al. Magnetic Resonance in Medicine (2021).

News | Magnetic Resonance Imaging (MRI) | May 06, 2021
May 6, 2021 — Magnetic Resonance Imaging
Research finds that a commonly used risk-prediction model for lung cancer does not accurately identify high-risk Black patients who could benefit from early screening

Getty Images

News | Lung Imaging | May 05, 2021
May 5, 2021 — Lung cancer is the third most common cance
After radiosurgery concurrent with nivolumab in 59-year-old patient with melanoma BM (patient 1; Supplemental Tables 3 and 5), F-18 FET PET at follow-up 12 weeks after treatment initiation (bottom row) shows significant decrease of metabolic activity (TBRmean, ?28%) compared with baseline (top row), although MRI changes were consistent with progression according to iRANO criteria. Reduction of metabolic activity was associated with stable clinical course over 10 mo. CE = contrast-enhanced. Image created by

After radiosurgery concurrent with nivolumab in 59-year-old patient with melanoma BM (patient 1; Supplemental Tables 3 and 5), F-18 FET PET at follow-up 12 weeks after treatment initiation (bottom row) shows significant decrease of metabolic activity (TBRmean, ?28%) compared with baseline (top row), although MRI changes were consistent with progression according to iRANO criteria. Reduction of metabolic activity was associated with stable clinical course over 10 mo. CE = contrast-enhanced. Image created by N. Galldiks et al., Research Center Juelich, Juelich, Germany.

News | PET Imaging | May 05, 2021
May 5, 2021 — For patients with brain metastases, amino acid ...